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Abstract
Pressure ulcers (PrUs) are among the most common secondary complications following spinal cord injury (SCI). External 
electrical current applied to a wound is believed to mimic the body’s natural bioelectricity and to restart and stimu-
late endogenous electrical fields to promote wound healing. A systematic review was conducted to critically appraise 
and synthesize updated evidence on the impact of electrical stimulation (ES) versus standard wound care (comprising 
cleansing, dressing, nutrition, and debridement as necessary) and/or sham stimulation on PrU healing rates in persons 
with SCIs. Medline, Embase, the Cumulative Index for Nursing and Allied Health Literature (CINAHL), PsycINFO, and 
Cochrane Central were searched using the terms spinal cord injury, electrical stimulation, and pressure ulcer in free text 
and MESH terms. Publications were limited to peer-reviewed, randomized controlled trials (RCTs) and non-RCTs (CCTs) 
published in English from 1985 to 2014. The methodological quality of the RCTs was evaluated using the Jadad scale; 
CCTs were assessed using the Downs and Black tool. Pooled analyses were performed to calculate the mean difference 
(MD) for continuous data, odds ratio (OR) for dichotomous data, and 95% confidence intervals (CI). A total of 8 trials were
reviewed — 6 RCTs and 2 CCTs included a total of 517 SCI participants who had at least 1 PrU. The number of patients
per study ranged from 7 to 150 and the number of wounds from 7 to 192. Comparison models included ES irrespective
of current type and placement of electrodes against sham/no ES (7 trials), ES delivered by electrodes overlaid on the
ulcer versus sham/no ES (4 trials), ES delivered by electrodes placed on intact skin around the ulcer versus sham/no ES
(4 trials), ES delivered by electrodes overlaid on the wound bed versus placed on intact skin around the ulcer (1 trial), ES
with pulsed current versus sham/no ES (6 trials), ES with constant current versus sham/no ES (2 trials), pulsed current ES
versus constant current ES (1 trial), number of PrUs closed (2 trials), and incidence of PrU worsened by ES versus sham/
no ES (2 trials). The overall quality of studies was moderate; 2 trials were rated as good quality, 2 were poor quality, and 4
were moderate. Evidence showed ES increased the rate of PrU healing in patients with SCI (MD 4.97, 95% CI 1.97–7.98, P
= 0.00; N = 7 studies and 559 ulcers), and a higher proportion of ulcers healed (OR 2.68, 95% CI 1.17–6.14, P = 0.02; N =
2 studies and 226 ulcers). The data suggest pulsed current ES increased the healing rate (MD 6.27, 95% CI 2.77–9.78, P
= 0.0005; N = 6 studies and 509 ulcers) more than constant current (MD 4.50, 95% CI 1.19–10.18, P = 0.12; N = 2 studies
and 200 ulcers). In addition, wounds with electrodes overlaying the wound bed seemed to heal ulcer faster than wounds
with electrodes placed on intact skin around the ulcer. Future preclinical, in vivo models and clinical trials examining the
impact of electrodes configuration for PrU healing are warranted.
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The National Pressure Ulcer Advisory Panel/European Pressure Ulcer Advisory Panel (NPUAP/EPUAP)1 de-
scribes a pressure ulcer (PrU) as an area of localized damage 
to the skin as a result of prolonged pressure alone or pressure 
in combination with shearing forces. A PrU is typically cat-
egorized into 4 key stages depending on ulcer depth and se-
verity. PrUs are among the most common secondary compli-
cations following spinal cord injury (SCI). According to the 
Model SCI System Statistical Centre,2 the annual incidence 
rate of PrUs is 14.7% in the first post-injury year and noted to 
steadily increase thereafter. It is estimated that up to 85% of 
people living with SCI develop a PrU during their lifetime.3-5
According to the NPUAP/EPUAP guideline,1 a systematic 
review of 12 studies,6 and a survey7 once a PrU has developed, 
it significantly increases the burden on the individual with 
SCI and/or his/her caregivers and has substantial detrimen-
tal impact on the quality of life, independence, and dignity 
of the patient. If a PrU is severe, it can lead to further dis-
abilities, need for surgical interventions, and fatal infections. 
Krause et al7 surveyed 1017 patients with SCI to examine the 
relationship between PrU and life adjustment after SCI and 
found PrUs adversely impacted nearly every area of life stud-
ied, including quality of life and independent living. 
Apart from personal consequences, PrUs also represent 
a significant cost burden for health and social care systems. 
According to the National Institute of Health and Care Excel-
lence (NICE) guideline,8 in addition to the costs of standard 
care, the daily costs of treating a PrU are estimated to range 
from £43 to £374 in the United Kingdom. Resources required 
for treating a PrU include nursing time, dressings, antibiotics, 
diagnostic tests, and high-specification, pressure-redistribut-
ing devices. Although the exact cost of PrU management in 
SCI is unknown, the total cost of treating PrUs has been es-
timated to be between £1.4 billion and £2.1 billion per year; 
the average cost to treat 1 Stage IV PrU is £14,108 per episode 
in the general population.9  
Treatment for PrUs can vary depending on the grade/stage 
of the ulcer. The standard care of PrUs varies across individu-
al settings. Although the management of PrUs recommended 
by clinical guidelines5,8 includes offloading, improving nutri-
tion, cleansing, debridement, and dressing, the general prin-
ciples of Stage I ulcer treatment incorporate pressure relief, 
careful clinical monitoring, cleansing, and dressings to pro-
mote hydration; Stage II ulcers may require pressure relief us-
ing a high-specification foam mattress/cushion or dynamic 
support surface and a moist dressing for reepithelialization; 
and Stage III and Stage IV ulcers usually require advanced 
nonsurgical or surgical treatment in addition to pressure 
relief; they also may require debridement and antibacterial 
treatment if systemic sepsis, cellulitis, or underlying osteo-
myelitis is clinically evident.
Electrical stimulation (ES) was proposed as a therapeutic 
modality for wound healing more than a century ago, and 
its use has been well documented in clinical studies since 
the 1960s, especially for wounds not responding to standard 
forms of treatment.10-16 Despite the fact ES has been dem-
onstrated in clinical studies13-16 to accelerate wound healing 
compared to no ES as conjunctive therapy, the understanding 
of the exact physiological mechanism remains incomplete. 
Animal models and in vitro preclinical studies9,17-31 provide 
some indication of the mechanism of ulcer healing enhanced 
by ES. Endogenous electrical fields (which measure electrical 
potentials) are known to naturally exist in the human body 
and are vital for tissue development and repair.17-19 The elec-
trical potential at the epidermis (transepithelial potential) is 
generated by intact skin through directional active ion trans-
portation, leading to the concentration of negative chlorine 
ions at the surface and positive sodium and potassium ions in 
the tissues. The epithelial layer of intact skin acts as an elec-
trical barrier. When a wound occurs, the epithelial barrier is 
broken, allowing the current to flow out of the wound. The 
transepithelial potential collapses and ions immediately be-
gin to leak out, establishing a weak but measurable current 
between the skin and inner tissues (the current of injury). 
The current is thought to continue until the skin defect is 
repaired.17-19 
Two main types of ES currents commonly noted in the 
literature are pulsed current (PC) and direct current (DC).17 
Constant, low-intensity DC involves applying continuous, 
unidirectional flow of current of low intensity (<1 mA) for at 
least 1 second. PC includes monophasic and biphasic wave-
forms: monophasic PC involves brief pulses of unidirectional 
flow of current followed by a finite off period, and biphasic 
PC consists of brief pulses of bidirectional current that has 
either a symmetric or asymmetrical biphasic waveform.17 
In symmetric biphasic PC, the bidirectional PC is equal and 
balanced, whereas asymmetric biphasic PC produces a bidi-
rectional current that is unequal and may or may not be bal-
Key Points
• Some pressure ulcer (PrU) guidelines of care include 
the recommendation to augment good wound care with 
electrical stimulation (ES) in patients with spinal cord 
injury (SCI) if ulcers are extensive and/or refractory.
• However, guidance on ES settings and applications is 
less readily available.
• The authors conducted a quantitative meta-analysis 
using available study data to increase understanding 
of how different settings of ES affect PrU healing.
• The results suggest ES is more effective than control 
treatments for healing PrUs in patients with SCI and 
that pulsed current ES increases the healing rate 
more than constant current ES.
• Questions about the optimal electrode configuration 
remain largely unanswered by this study. 
Ostomy Wound Management 2016;62(7):16≠34
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anced. Balanced asymmetric biphasic PC has no net positive 
or negative charge; unbalanced asymmetric biphasic PC cre-
ates a net positive or negative charge over time.17   
Application of an external electrical current to a wound 
is believed to mimic the body’s natural bioelectricity and to 
restart and stimulate endogenous electrical fields and as such, 
promote wound healing.20-22 ES has been demonstrated in 
both in vitro23-26 and animal in vivo27 studies to enhance cel-
lular activities such as collagen and DNA synthesis, ATP con-
centration, and generation of chemotaxic factors.24-27 ES also 
has been shown in vitro and in vivo studies25,27-31 to increase 
tissue perfusion, decrease edema, and promote angiogenesis 
and galvanotaxis compared to no ES stimulation, directing 
and accelerating the process of endothelial migration in the 
wound tissue to promote wound healing.
In a clinical study, Baker et al13 assessed 3 different forms 
of ES current for pressure healing among 192 PrUs in 80 pa-
tients with SCI who were treated for 45 minutes/day for 4 
weeks. The authors reported ES enhanced PrU healing by 
measuring percentage changes of wound surface area per 
week in comparison with no ES in SCI. In addition, the au-
thors identified asymmetric biphasic waveform of electrical 
current as the optimal wound healing protocol in compari-
son with microcurrent and without ES. Mittmann et al32 con-
structed a decision analytic model over a 1-year period to de-
termine the incremental cost effectiveness of ES plus standard 
wound care (SWC), typically comprised of nonsurgical pro-
cedures such as debridement, dressing, nutritional, physical 
Figure 1. Literature search screening flow chart. PU=pressure ulcer; SCI=spinal cord injury; ES=electrical stimulation
DO
NO
T D
UP
LIC
AT
E
4     OSTOMY WOUND MANAGEMENT®  JULY 2016 www.o-wm.com
FEATURE
Ta
bl
e 
1
. 
C
ha
ra
ct
er
is
ti
cs
 o
f 
st
ud
ie
s 
re
vi
ew
ed
A
u
th
o
r,
 
ye
ar
, 
re
fe
re
n
ce
,  
co
u
n
tr
y
N
u
m
b
er
 o
f 
p
at
ie
n
ts
 
(P
rU
s)
 C
o
m
p
ar
is
o
n
 I
=
In
te
rv
en
ti
o
n
, 
C
=
co
n
tr
o
l
Ty
p
e 
o
f 
E
S
E
S
 p
ar
am
et
er
s 
(p
u
ls
e 
d
u
ra
-
ti
o
n
, f
re
q
u
en
cy
, 
in
te
n
si
ty
) 
E
le
c
tr
o
d
e 
ch
ar
-
ac
te
ri
st
ic
s 
(lo
ca
-
ti
o
n
, m
at
er
ia
l, 
si
ze
)
S
tu
d
y 
p
er
io
d
O
u
tc
o
m
e 
m
ea
su
re
s
M
et
h
o
d
o
lo
g
ic
al
 
q
u
al
it
y
R
C
T
H
o
ug
ht
o
n 
et
 a
l (
20
10
)4
0  
C
an
ad
a
34
 (3
4)
I: 
E
S
 p
lu
s 
S
W
C
 
p
ro
g
ra
m
; C
: S
W
C
 
o
nl
y 
w
ith
ou
t 
E
S
.
P
ul
se
d
 c
ur
re
nt
 
50
 µ
s,
 1
00
H
z 
an
d
 
10
H
z,
 5
0
–1
50
 V
 
O
n 
w
ou
nd
 b
ed
; 
N
R
, 4
.8
 c
m
 x
 
10
.2
 c
m
3 
m
o
nt
hs
 
 W
S
A
Lo
w
 r
is
k 
of
 b
ia
s 
Ja
d
ad
 3
, A
C
 y
es
, 
IT
T 
ye
s
G
ri
ffi
n 
et
 
al
 (1
99
1)
3
9  
  
U
S
A
17
 (1
7)
I: 
E
S
 p
lu
s 
st
an
-
d
ar
d
 n
ur
si
ng
 c
ar
e 
p
ro
g
ra
m
;  
C
: S
ha
m
 
E
S
 p
lu
s 
st
an
d
ar
d
 
nu
rs
in
g 
ca
re
P
ul
se
d
 c
ur
re
nt
 
75
 µ
s,
 1
00
 p
p
s,
 
20
0v
O
n 
w
ou
nd
 b
ed
, 
al
um
in
iu
m
 p
la
te
; 
la
rg
er
 t
ha
n 
ul
ce
rs
20
 d
ay
s
 W
S
A
Lo
w
 r
is
k 
of
 b
ia
s 
Ja
d
ad
 4
, A
C
 y
es
, 
IT
T 
no
A
d
eg
o
ke
  e
t 
al
 (2
00
1)
3
8  
N
ig
er
ia
7 
(7
)
I: 
E
S
 p
lu
s 
S
W
C
; C
: 
S
ha
m
 E
S
 p
lu
s 
S
W
C
P
ul
se
d
 c
ur
re
nt
N
R
, 3
0H
z,
 
su
b
m
ot
o
r
O
n 
w
ou
nd
 b
ed
, 
al
um
in
iu
m
 p
la
te
; 
la
rg
er
 t
ha
n 
ul
ce
rs
’ 
p
er
im
et
er
s
4 
w
ee
ks
 W
S
A
M
o
d
er
at
e 
b
ia
s 
Ja
d
ad
 2
, A
C
 y
es
, 
IT
T 
no
B
ak
er
 e
t 
al
 
(1
99
6)
13
  U
S
A
80
 (1
92
)
I: 
as
ym
m
et
ric
 b
i-
p
ha
si
c 
E
S
; I
I: 
sy
m
-
m
et
ric
 b
ip
ha
si
c 
E
S
; 
III
: m
ic
ro
cu
rr
en
t 
E
S
; 
C
: N
o 
E
S
 t
re
at
m
en
t 
P
ul
se
d
 c
ur
re
nt
  
I: 
10
0 
µs
, 5
0 
H
z,
 
su
b
m
ot
o
r
II:
 3
00
 µ
s,
 5
0 
H
z,
 
su
b
m
ot
o
r
III
: 1
0 
µs
, 1
 H
z,
 
4m
A
E
d
g
e 
of
 u
lc
er
, 
ca
rb
o
n-
ru
b
b
er
, 
2.
5 
cm
 x
 2
.5
 c
m
 t
o 
5 
cm
 x
 1
0 
cm
4 
w
ee
ks
H
ea
lin
g 
ra
te
 
an
d
 W
S
A
M
o
d
er
at
e 
b
ia
s 
Ja
d
ad
 2
, A
C
 n
o,
 
IT
T 
no
Je
rc
in
o
vi
c 
et
 a
l (
19
94
)4
1  
S
lo
ve
ni
a
73
 (1
09
)
I: 
S
W
C
 p
lu
s 
E
S
; C
: 
S
W
C
. C
ro
ss
ov
er
 
g
ro
up
 a
ft
er
 4
 w
ee
ks
P
ul
se
d
 c
ur
re
nt
.
25
0u
s,
 4
0H
z,
 u
p
 
to
 4
5m
A
E
d
g
e 
of
 u
lc
er
, 
se
lf-
ad
he
si
ve
, 5
 
cm
 x
 7
.5
 c
m
4 
w
ee
ks
H
ea
lin
g 
ra
te
M
o
d
er
at
e 
b
ia
s 
Ja
d
ad
 1
, A
C
 n
o,
 
IT
T 
ye
s
K
ar
b
a 
et
 
al
 (1
99
7)
42
 
S
lo
ve
ni
a
50
 (5
0)
I: 
 E
S
 w
ith
 p
o
si
tiv
e 
el
ec
tr
o
d
e 
ov
er
la
id
 
ul
ce
r 
an
d
 4
 n
eg
a-
tiv
e 
el
ec
tr
o
d
es
 la
id
 
ar
ou
nd
 u
lc
er
; I
I: 
S
am
e 
E
S
 p
ro
g
ra
m
 
w
ith
 2
 e
le
ct
ro
d
es
 
la
id
 o
n 
in
ta
ct
 s
ki
n 
at
 t
he
 u
lc
er
 e
d
g
e 
ac
ro
ss
 w
ou
nd
; 
C
: S
ha
m
 E
S
. A
ll 
g
ro
up
s 
re
ce
iv
ed
 
S
W
C
C
o
ns
ta
nt
 d
ire
ct
 
cu
rr
en
t 
N
A
, N
A
, 0
.6
 m
A
I: 
O
ve
rla
id
 t
he
 
ul
ce
r;
 r
ub
b
er
 
el
ec
tr
o
d
es
; N
R
; 
II:
 e
d
g
e 
of
 u
lc
er
, 
se
lf-
ad
he
si
ve
 
el
ec
tr
o
d
es
, N
R
N
ot
 r
ep
o
rt
ed
R
el
at
iv
e 
he
al
in
g 
ra
te
 
M
o
d
er
at
e 
b
ia
s 
Ja
d
ad
 2
, A
C
 n
o,
 
IT
T 
no
co
nt
in
ue
d
 o
n 
ne
xt
 
p
ag
e
co
nt
in
ue
d
 o
n 
ne
xt
 p
ag
e
DO
 N
OT
 D
UP
LIC
AT
E
JULY 2016  OSTOMY WOUND MANAGEMENT®     5www.o-wm.com
ELECTRICAL STIMULATION IN PRESSURE ULCER HEALING
therapies, and surgical procedures for the management of complica-
tions in comparison with SWC alone in SCI with Stage III and Stage IV 
(per the NPUAP) PrUs. The authors assessed PrU healing using healing 
rates, recurrence rates, and complication rates; ES also reduced the cost 
of care in the SCI population. Furthermore, the most recent NPUAP/
EPUAP clinical guideline5 recommends the use of ES to facilitate wound 
healing in recalcitrant Category/Stage II PrUs as well as any Category/
Stage III and Stage IV PrUs in patients with SCI. However, the lack of 
consistency in the use of stimulation mode and parameters, together with 
the small sample size in the individual published trials, makes it difficult 
for health professionals and health providers to make clinical decisions 
on the implementation of ES treatment for PrU. 
Purpose
The purpose of this quantitative meta-analysis was to increase un-
derstanding of how different settings of ES affect PrU healing. Pooled 
analysis that quantitatively calculates weighted averages of findings 
across multiple trials can increase the statistical power of the existing 
small sample size of individual studies, enriching understanding of in-
consistent results encountered across individual studies.
The aims of this review were 1) to assess the effect of ES as an ad-
junctive therapy for PrU on the weekly healing rate in people with SCI 
when compared to sham stimulation or no ES treatment; 2) to explore 
whether different types of ES currents and electrode placement have 
any influence on the healing rate of PrUs; and 3) to examine whether ES 
treatment worsens PrU in SCI as compared to no ES treatment.
  
Methods
Literature search. The original systematic review protocol33 regis-
tered in the PROSPERO database in July 2013 (www.crd.york.ac.uk/
PROSPERO; registration number CRD42013005088) was updated 
to include more recent research up to July 3, 2014. Material from the 
original study plus new findings are analyzed. As before, full reports of 
randomized, controlled trials (RCTs) and nonrandomized, clinical con-
trolled trials (CCTs) were identified through searches of the Medline, 
Embase, the Cumulative Index for Nursing and Allied Health Litera-
ture (CINAHL), PsycINFO, and the Cochrane Central Register of Con-
trolled Trials without language restrictions. Search terms included spi-
nal cord injury, electrical stimulation, and pressure ulcer. All searched hits 
were exported to Endnote (Endnote version X7 for Windows, Thomson 
Reuters). All titles and abstracts were screened for eligibility, and the 
full text of potentially relevant articles was retrieved and considered 
for inclusion by the first author. Each stage of the selection process was 
cross-checked by the second author.  Any disagreement was discussed 
or consulted by the third author.
Literature inclusion/exclusion criteria. 
Target population. Persons with SCI and any categorical grade or 
any number of PrUs irrespective of age, gender, and level and degree 
of severity of traumatic or nontraumatic injury were included. Stud-
ies with a mixed-study population that included individuals with SCI 
were included if the ulcer outcomes were reported/analyzed separate-
ly for SCI participants. 
Type of intervention. All types of ES using 2 or more surface elec-
trodes placed on the wound bed or in the edge of wound bed were Ta
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included.
Type of studies. RCTs and CCTs that compared any type 
of ES against SWC consisting of cleansing, dressing, debride-
ment and nutrition without ES or sham ES that were pub-
lished in an indexed, peer-reviewed journal between January 
1985 and July 2014 were included. Conference abstracts and 
university theses were excluded. 
Outcome. The publication needed to report ulcer outcome 
measurement (eg, wound size or average healing rate per day, 
per week, or during whole study period).
Data extraction and methodological quality. The follow-
ing data were extracted from eligible articles by 1 reviewer 
(LL) and cross-checked by the second reviewer: year of publi-
cation, country of author, and type of study design. All other 
data, including quality assessment, were assessed indepen-
dently by 2 reviewers. This included sample size; participant 
age, gender, and type and level of SCI; the type of ES; the 
duration and pattern of stimulation; electrode placement; 
follow-up duration; and adverse events. Additionally, data 
extraction included outcome measures on the percentage 
change in wound surface area or changes in ulcer size. Any 
disagreement in assessed findings between the 2 independent 
reviewers was resolved by discussion or through consultation 
with a third reviewer. 
Each publication was subjected to a quality assessment. 
For RCTs, a Jadad score (University of Oxford, Oxford, UK) 
was used together with the item allocation concealment and 
consideration as to whether the analysis was based on the 
randomized groups.33-35 A modified Downs and Black tool 
(London School of Hygiene and Tropical Medicine, London, 
UK) was used for CCTs.36,37 Both scales are well-established 
tools for assessing and reporting the quality of clinical and 
health-related studies in the literature. The Jadad score in-
dependently assesses the methodological quality of a clini-
cal trial and has known reliability and external validity.37 It 
contains an assessment — namely, risk of bias (selection bias, 
performance bias, detection bias, attrition bias) — and is rel-
atively easy to use. The Jadad score addresses items relating to 
randomization, blinding, and description of withdrawals and 
dropouts, with scores ranging from 0 to 5 (trials scoring 3 or 
greater are considered to be of reasonably good quality). In 
addition to the Jadad score, 2 extra items were added: alloca-
tion concealment and intent-to-treat (ITT) analysis, which 
deal with reporting bias and performance bias for open-label 
(nonblinded) trials. Allocation concealment was considered 
adequate if patients and investigators who enrolled patients 
could not foresee treatment assignment. ITT is defined as 
an analysis that demonstrates inclusivity of all randomized 
participants based on specified criteria and includes all ran-
domized patients in the groups to which they were randomly 
Figure 2. Weekly healing rate with electrical stimulation (ES) treatment versus without ES treatment in 7 studies.
Figure 3. Weekly healing rate using pulsed current versus without electrical stimulation treatment.
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assigned, regardless of 1) their adherence with the entry cri-
teria, 2) the treatment they actually received, and 3) subse-
quent withdrawal from treatment or deviation from the pro-
tocol.34 The Downs and Black tool37 consists of 27 questions 
that evaluate the level of 4 domains: reporting, external valid-
ity, internal validity (both bias and confounding), and power. 
Each question was scored as Yes (1) or No/Unknown (0). Be-
cause question 5 addressed 2 components (Are the distribu-
tions of principal confounders in each group of subjects to 
be compared clearly described? A list of principal confound-
ers is provided), the full score for the question was 2. Ques-
tion 27 was modified slightly due to an ambiguity in the first 
component (Did the study have sufficient power to detect 
a clinically important effect where the probability value for 
a difference being due to chance is <5%? Sample sizes have 
been calculated?); only the second part of the question was 
assessed. For example, if the sample size was calculated by a 
trial, it was scored yes (1). The total score of the 27 questions 
was calculated by adding up the scores; thus, the highest score 
any reviewed article could receive was 28. It should be noted 
that scores increased in line with the methodological quality 
of the study; higher scores indicated higher methodological 
quality.37 
Data analysis. Data were extracted to a spreadsheet. A 
quantitative pooled analysis was performed to estimate the 
pooled ES treatment effect on weekly healing rates, the num-
ber of ulcers healed, and the incidence of ulcers worsening. 
All trials included in this review defined ulcer healing in 
terms of changes in wound surface area either per week, per 
day, or during the whole study follow-up. Because the daily 
healing rate has limited clinical relevance, for those trials that 
reported percentage of ulcer decrease per day or during the 
whole study period, the weekly healing rate was calculated 
and used for pooled analysis. Weekly healing rate was defined 
as the mean percentage change in ulcer size per week. Review 
Manager (Review Manager (RevMan), Version 5.3. Copenha-
Figure 4. Weekly healing rate by constant direct electrical stimulation (ES) versus without ES treatment.
Figure  5. Weekly healing rate by electrical stimulation (ES) with electrode overlying wound versus without ES treat-
ment.
Figure 6. Weekly healing rate by electrical stimulation (ES) with both electrodes on intact skin versus without ES treat-
ment.
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gen: The Nordic Cochrane Centre, The Cochrane Collabora-
tion, 2014) was used to pool the healing rate per week and the 
number of ulcers completely healed and ulcers that worsened 
among the studies. 
All data irrespective of the length of treatment and follow-
up were analyzed. Weekly healing rate was compared between 
patients who had ES and patients who had no ES treatment. 
Subgroup analysis was performed for good quality RCTs. The 
weekly healing rate between PC and constant DC and elec-
trode overlaid versus placed at edge of ulcer were compared. 
For those trials with more than 2 arms, the ES arm with the 
largest sample was included for comparison with the con-
trol arm (no ES/sham ES). Treatment effect was significant 
if P <0.05. Heterogeneity between studies was tested with 
the use of the chi-square test (significant if P <0.1) and I2 
test (with substantial heterogeneity defined as values >50%). 
When studies showed significant heterogeneity (I2  >50%), 
the Mantel–Haenszel random effects model was used to cal-
culate mean difference. Otherwise, the fixed effects model 
(I2  <50%) was used to calculate the pooled effect sizes when 
studies did not show heterogeneity.
Results
Studies. The literature search identified a total of 407 
unique references; all were exported to Endnote, along with 
3 additional articles identified from other sources. Of these 
410 articles, 127 were identified as duplicates, resulting 283 
abstracts and titles. These were further screened for eligibil-
ity, generating 80 potentially relevant abstracts that were re-
trieved and considered for inclusion in the final review. Of 
these, 8 (6 RCTs13,38-42 and 2 nonrandomized CCTs43,44) met 
the inclusion criteria and were subjected to full-data extrac-
tion and quantitative analysis. Figure 1 provides a flow chart 
of the process and results for screening eligibility and study 
selection.
All 8 studies described the study target population as per-
sons with SCIs who had at least 1 PrU. The number of pa-
tients per study ranged from 7 to 150, with the number of 
ulcers studied ranging from 7 to 192. Four (4) studies (N = 
415 ulcers) measured mean daily percentage change in ulcer 
size,41-44 1 study (N = 192 ulcers) measured the mean weekly 
percentage change in ulcer size,13 and 3 studies (N = 58 ul-
cers) measured mean percentage change in ulcer size across 
the entire study period.38-40 Six (6) out of 8 trials (N = 509 
ulcers) compared PC ES to sham/no ES treatment,13,38-41,44 1 
trial (N = 50 ulcers) compared constant current ES to sham 
ES treatment,42 and 1 (N = 150 ulcers) compared PC ES to 
constant current ES therapy or sham ES.43 For stimulus pulse 
settings, stimulation varied from 40 Hz to 100 Hz in frequen-
cy and from 50 V to 150 V (or 4 mA to 45 mA) in intensity.
In terms of electrodes placement, in 3 studies38-40 (N = 
58 ulcers) the electrodes were overlaid on wound bed, in 4 
studies (N = 557 ulcers) the electrodes were applied to intact 
skin around the wound,13,41,43,44 and in 1 (N = 50 ulcers) ES 
treatment compared electrodes overlaid on the wound bed to 
electrodes placed on intact skin around the ulcers.42 Details 
of sample characteristics are shown in Table 1. 
Methodological quality. One (1) of the 6 RCTs described 
an appropriate method to generate the randomization se-
quence,40 2 were double-blinded and described the method 
Figure 7. Number of pressure ulcers healed during study period with versus without electrical stimulation (ES) treat-
ment. 
Figure 8. Incidence of pressure ulcers worsened with versus without electrical stimulation treatment .
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of double-blinding,39,42 3 adequately described allocation 
concealment,38-40 and 2 used ITT to analyze the data.40,41 Two 
(2) RCTs were considered to be of reasonably good meth-
odological quality according to the Jadad score along with 
2 other items; hence, they were classified as low risk of bias 
trials.39,40 The remaining 4 RCTs were considered to exhibit 
moderate risk of bias.13,38,41,42 Two (2) nonrandomized CCTs 
were assessed for their reporting quality using the Down 
and Black tool, scoring 13 and 8, respectively, out of a total 
achievable score of 28 and subsequently considered relative 
high risk of bias trials.43,44 
Data pooling and meta-analysis.
Effectiveness of ES. ES effectiveness was assessed according 
to mean weekly healing rate (ie, average percentage change 
per week in ulcer size), the number of ulcers healed, and 
the incidence of ulcers worsening (defined as wound size 
increased during study period), comparing different ES set-
tings and/or how ES performed versus sham or no treatment. 
With regard to overall healing rate by ES versus sham/no 
ES, the pooled analyses of the 7 relevant trials showed people 
receiving ES treatment in addition to conventional wound 
treatment (which involved cleansing, dressing, nutrition, and 
debridement as necessary) reporting a higher weekly healing 
rate than those without ES treatment by 4.97% (MD 4.97, 
95% CI 1.97-7.98, P = 0.001) (see Figure 2). However, het-
erogeneity among the studies was substantial (I2 = 83%, P 
<0.00001). A subgroup analysis of RCTs considered to be of 
good methodological quality showed a trend toward a higher 
weekly healing rate in people treated with ES than people 
without ES treatment, but the pooled effect was not signifi-
cant (P = 0.07). 
When healing rate by PC ES versus sham/no ES was as-
sessed, the pooled analysis of the 6 trials13,38-41,43 showed a 
significantly higher weekly healing rate in people who were 
treated with PC ES than those without ES treatment (MD 
6.27, 95% CI 2.77-9.78, P = 0.0005, I2  = 74%( (see Figure 3).
When healing rate by constant DC versus sham/no ES 
was compared, the pooled analysis of the 2 trials in which 
constant current ES was applied showed a nonsignificantly 
higher weekly healing rate in people treated with constant 
current than those without ES (MD 4.50, 95% CI 1.19-10.18, 
P = 0.12, I2  = 0% (see Figure 4).
With regard to healing rate by PC versus DC ES treat-
ment, 1 CCT43 compared PC ES treatment versus DC for PrU 
healing. A higher weekly healing rate was achieved by PC ES: 
5.43% to 4.40% per day versus 3.11% to 3.83% per day, re-
spectively (P = 0.03). 
Healing rate by electrode placement also was assessed 
(ie, active electrode overlaid the wound bed versus sham/no 
ES). A meta-analysis of the 4 trials38-40,42 that applied the ac-
tive electrodes directly on the wound found a significantly 
higher rate with ES irrespective of current type than without 
ES (MD 9.01, 95% CI 2.02-16.00, P = 0.01, I2 = 90%) (see 
Figure 5).  
When electrode placement on intact skin was analyzed, 
the pooled analysis of the healing rate for the 4 trials13,41-43 
where both electrodes were placed on intact skin/the edge 
of wound versus sham/no ES showed a significantly higher 
weekly healing rate in people who received ES than those 
who received no ES (MD 7.71, 95% CI 1.59-13.83; P = 0.01, 
I2 = 79%) (see Figure 6). 
The healing rate when the active electrode overlaid the 
wound bed was compared to electrodes placed on intact 
skin/the edge of wound. One (1) study42 compared the effect 
of ES delivered by applying the electrodes either directly on 
the wound bed or on the edge/intact skin around the ulcer 
versus sham ES treatment. In group 1, the positive electrode 
overlaid the ulcer and 4 negative electrodes were laid around 
the ulcer; in group 2, 2 electrodes were laid on intact skin 
at the ulcer edge across the wound; and in group 3, 2 elec-
trodes were laid on intact skin at the ulcer edge across the 
wound without ES delivery. The authors reported electrodes 
that overlaid wound bed achieved a higher healing rate than 
electrodes placed on intact skin around the ulcer or sham 
ES group (1.6%/day overlaid versus 4.8±1.5%/day versus 
4.2±11%/day). 
Two (2) trials13,40 addressed the number of ulcers com-
pletely healed by ES versus sham/no ES. Both trials report-
ed a higher number of ulcers completely healed in the ES 
treatment group (52% and 37%, respectively13,40) compared 
to sham/no ES treatment (24% and 28%, respectively13,40). 
Pooled analysis of these 2 trials showed significantly higher 
numbers of ulcers (N = 226 ulcers) healed with ES treatment 
(OR 2.68, 95% CI 1.17–6.14, P = 0.02, I2  = 0%) (see Figure 
7).
Two (2) studies40,41 reported the incidence of ulcers that 
worsened during the study period compared to sham/no 
treatment. Both trials reported lower number of ulcers wors-
ened in individuals who had ES treatment (N = 143 ulcers). 
However, the pooled analysis of these 2 trials showed the dif-
ference was nonsignificant (OR 0.38, 95% CI 0.12–1.24, P = 
0.11, I2  = 18%) (see Figure 8). 
Adverse events. Only 1 of the 8 studies40 reported adverse 
events. The authors indicated some patients experienced 
minor adverse reactions related to ES, which included red, 
raised, itchy skin beneath the large dispersive electrode. One 
(1) patient had a persistent (>24 hour) redness or burn un-
der the active electrode, presumably from too high a stimulus 
intensity, which resolved within 48 hours.
Discussion
ES has been recommended for use in the treatment of 
PrUs in recent (2014) NPUAP/EPUAP guidelines, yet the spe-
cifics for ES are not clear. The comparison of ES current types 
and placement of electrodes reported in the present review 
should provide new insights for clinicians who treat PrU in 
the SCI population. Of the 8 studies that met inclusion cri-
teria and were included in this review, 6 were RCTs13, 38-42 and 
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2 were nonrandomized CCTs.43,44 Two (2) of the 6 RCTs39,40 
were classified as having good quality of evidence according 
to the Jadad scale; they used allocation concealment and ITT 
analysis. The other 4 RCTs13,38,41,42 were classified as moderate 
quality, and the remaining 2 nonrandomized43,44 CCTs pro-
vided a relatively low level of evidence. As a whole, the 8 trials 
provided a moderate level of evidence.
In terms of effectiveness, the quantitative pooled analysis 
of the 7 controlled trials showed an average higher weekly 
healing rate during the treatment period when patients re-
ceived ES in addition to SWC of cleansing, dressing, nutri-
tion, and debridement as necessary. Of the 8 trials included 
in the review, 2 studies13,40 (N = 226 ulcers) reported the 
number of ulcers completely healed during the study period 
(OR 2.68, 95% CI 1.17–6.14); significantly more PrUs healed 
with ES treatment in comparison to sham ES or no ES treat-
ment (P = 0.02). Two (2) trials40,41 reported fewer ulcers wors-
ening when patients received ES treatment. These 2 trials also 
showed a trend toward higher weekly healing in the ES group, 
although the difference was not significant between ES treat-
ment and control groups. 
In addition to supporting the recommendations of the 
most recent NPUAP/EPUAP clinical guidelines5 regarding 
the application of ES for recalcitrant PrU healing in persons 
with SCI, the current findings are also in agreement with pre-
vious studies demonstrating ES enhances PrU healing in the 
SCI population45 and chronic wound healing in the non-SCI 
population.11-16 A systematic review conducted by Lala et al45 
reported the risk of PrU healing during the study period (20 
days to 3 months) together with daily healing rate (percent-
age decreased per day) in SCI. The authors concluded ES 
seems to be an effective adjunctive therapy to accelerate and 
increase PrU closure in individuals with SCI. In the cur-
rent review, the calculated weekly healing rate was anec-
dotally suggested by clinicians and tissue viability special-
ists to be more clinically relevant than simply describing 
the positive outcomes of previous research. In addition, 
the types of ES current and placements of electrodes, pre-
sented along with the incidence of worsening PrUs, should 
be of interest to clinicians.  
The constant DC that involves unidirectional continuous 
flow of current for longer than 1 second has been associated 
with an antibacterial effect in PrU healing, but it can cause 
chemical and thermal burns.46 This type of ES was employed 
in 2 of the studies42,43 reviewed. The most commonly used 
ES for PrU healing in the review was PC that involved no si-
nusoidal, interrupted current flow for a brief period of time. 
It is suggested that PC ES more closely mimics the “current 
of injury” necessary for triggering tissue healing by sustained 
activation of the voltage-gated sodium channels in the sur-
rounding tissues.24 As compared with continuous DC stimu-
lation, PC ES may carry a lower risk of possible skin burns 
and a greater depth of penetration.10,24,46,47 PC ES was utilized 
in 6 out of 8 studies (N = 465 ulcers).13,38-42 Pooled analysis of 
6 trials showed PC ES significantly improved weekly healing 
rate compared with no ES. 
Three (3) studies involved placing the active electrode di-
rectly on the wound bed and the negative electrode on the 
intact skin around the edge of the ulcer.38-40 Four (4) stud-
ies reported the negative and positive electrodes were placed 
on opposite sides of the PrU on intact skin.13,41,43,44  One (1) 
study42 compared electrode placement (1 group of partici-
pants received ES by applying the ES with positive electrode 
overlaid on the ulcer and 4 negative electrodes laid around 
ulcer, while the other group received ES by applying same ES 
program with 2 electrodes laid on the intact skin at the ul-
cer edge across wound; the participants in the control group 
received sham ES treatment with 2 electrodes laid on the in-
tact skin at the ulcer edge across wound). The authors found 
participants who received ES by electrodes overlaid on the 
wound bed had a higher healing rate than the participants 
who received ES by electrode placed surrounding the wound. 
Electrode polarity has long been thought a complex issue 
in the literature. For instance, anodal stimulation was shown 
to increase fibroblast migration,31,48 while cathode stimula-
tion enhanced keratinocyte migration22 and increased fibro-
blast proliferation.46 Both anodal and cathode stimulation 
have an antibacterial effect, with cathode stimulation seem-
ing to have greater antibacterial effects.48,49 In the current 
endeavor, only 1 study42 compared electrode configuration 
by either placing the active electrode in the wound and the 
dispersive electrode at a distance from the ulcer versus plac-
ing both electrodes on the edge of ulcer. Although the average 
weekly healing rate was significantly higher when active elec-
trodes overlaid the wound surface than when electrodes were 
placed surrounding the wound, this study was not a RCT and 
was classified as low level of evidence with high risk of bias. 
Such results should be interpreted with caution. Thus, the as-
sessment of the different effects between 2 types of electrodes 
placement for PrU healing is inconclusive. Future preclini-
cal, in vivo models and clinical trials examining the impact of 
electrode configuration on PrU healing are warranted.
Limitations
Although systematic reviews and meta-analyses have 
their own merits in terms of increasing the statistical power 
of the small sample size of individual studies, conducting 
such analyses often presents a number of limitations. These 
include publication bias (particularly against negative find-
ings), language restrictions, heterogeneity across each stud-
ies, and coding of keywords. The small number of relevant 
trials, together with substantial heterogeneity in this review, 
made it difficult to interpret some findings and draw firm 
conclusions. Higher heterogeneities evident across the trials 
in this review can be explained by the variation of study de-
sign and stimulation parameters (stimulation frequency, in-
tensity, waveform) and stimulation device used. 
Another limitation of the study was the use of the Jadad 
DO
 N
OT
 D
UP
LIC
A
E
JULY 2016  OSTOMY WOUND MANAGEMENT®     11www.o-wm.com
ELECTRICAL STIMULATION IN PRESSURE ULCER HEALING
scale for assessing methodology quality of RCTs. Although 
the Jadad scale is a well-established tool and is widely used 
for assessing and reporting the quality of clinical and health-
related studies in the literature, it has shortcomings. The 
Jadad scale is criticized for being oversimplistic, placing too 
much emphasis on blinding and exhibiting low consistency 
between different raters. Furthermore, it does not take into 
account allocation concealment. However, in this review, 2 
assessment items (allocation concealment and ITT analysis) 
were added. The methodological quality of CCTs was as-
sessed using the Downs and Blacks tool, a well-established as-
sessment tool used in SCI literature35; however, it features no 
cut-off point for definition of good or poor CCTs. Future re-
views should consider using 1 assessment tool for both RCTs 
and CCTs. Nevertheless, the methodology for each article 
also was assessed independently by 2 authors, and consensus 
was achieved and disagreement was discussed between them. 
A further limitation is the exclusion of non-English lan-
guage literature. Although adding non-English articles may 
have strengthened the current review, the language restric-
tion cannot be avoided due to lack of interpretation resourc-
es. To minimize the limitation, the authors adopted a well-
structured search strategy that was approved by a clinical 
librarian, supplemented all “explode” functions, and utilized 
hand searches as well as contacting specialists to minimize 
the potential bias. 
In addition to types of ES current and electrode place-
ment, other parameters (such as material, size of electrodes, 
level of injury, quality of life, hospital stay, pain, and cost to 
patients and carers) also may have an impact on PrU healing. 
Unfortunately, incomplete reporting of such data was identi-
fied in the current review — for instance, only 1 trial40 in this 
review reported the level of injury and the majority of tri-
als failed to report the size or material of electrodes used for 
ES treatment. Such data should be reported in future clinical 
studies.
 
Conclusion
ES appears to help facilitate PrU healing in the SCI pop-
ulation. Pulsed DC ES confers better benefits for PrU heal-
ing than constant DC. PrUs in people who had ES treat-
ment seem more likely to completely close and less likely to 
worsen than ulcers in people who had no ES treatment. ES 
has been recommended for Stage III and Stage IV ulcers and 
for recalcitrant Stage II PrU healing by the NPUAP/EPUAP, 
yet the NICE guideline8 recommends not to use ES for PrU 
healing. Health professionals and the health service need 
well-designed clinical studies involving large sample popula-
tions to determine the optimal stimulation parameters and 
stimulation location with the most beneficial effect on the 
enhancement of PrU healing in SCI. Although an electrode 
directly placed on the wound bed may be more efficient than 
all electrodes placed on intact skin around the wound, more 
rigorous preclinical studies and clinical trials on determining 
the optimal stimulation parameters (eg, type of ES current 
— in particular, constant DC versus PC that were commonly 
used for PrU healing in SCI), locations of electrodes, materi-
al, and size of electrodes are warranted. To better understand 
the exact physiological basis of ES for enhancing PrU healing, 
research is urgently needed in the form of more preclinical in 
vivo models to identify the optimal mode of ES current and 
electrode placement (polarity). n
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